Acetic Acid

Acetic Acid

SCHEMBL896270

CC(=O)O.CC(=O)O.CC(=O)O.CCC(NCCN)[Si](OC)(OC)OC

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 3/20 0.33
GGT1 P19440 1/20 0.33
CPB1 P15086 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL22342078 1.00 CPB2 (0.33) CPB2GGT1CPB1
Acetic Acid SCHEMBL2347225 0.98 CPB2 (0.32) CPB2GGT1CPB1
Acetic Acid SCHEMBL896859 0.98 CPB2 (0.32) CPB2GGT1CPB1
Acetic Acid SCHEMBL28616089 0.98 CPB2 (0.32) CPB2GGT1CPB1
Acetic Acid SCHEMBL28382954 0.90
SCHEMBL361861 0.89
SCHEMBL2145475 0.89
SCHEMBL28403106 0.88
Isopropyl Alcohol SCHEMBL6557543 0.86
Acetic Acid SCHEMBL5069778 0.85 CPB2 (0.32) CPB2GGT1CPB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114177897-B Preparation method and application of silane modified cyclodextrin-based adsorbent 华东理工大学 2023-11-07 CN claimed
US-20220161240-A1 METHOD FOR OBTAINING METAL OXIDES SUPPORTED ON MESOPOROUS SILICA PARTICLES Technische Universität Berlin (DE) 2022-05-26 US claimed
US-11318442-B2 Method for producing core-shell hybrid materials COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2022-05-03 US claimed
CN-111529721-B Self-polymerization type nano diagnosis and treatment system and preparation method and application thereof 四川大学 2021-08-31 CN claimed
CN-112423634-A Odor-proof cover 埃戴拉公司 2021-02-26 CN claimed
WO-2020225366-A1 METHOD FOR OBTAINING METAL OXIDES SUPPORTED ON MESOPOROUS SILICA PARTICLES Technische Universität Berlin (DE) 2020-11-12 WO claimed
EP-2714225-B1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORP (US) 2020-11-11 EP claimed
EP-3736249-A1 METHOD FOR OBTAINING METAL OXIDES SUPPORTED ON MESOPOROUS SILICA PARTICLES Technische Universität Berlin (DE) 2020-11-11 EP claimed
US-20200332028-A1 CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASIC MOIETIES WATERS TECHNOLOGIES CORPORATION 2020-10-22 US claimed
CN-111529721-A Self-polymerization type nano diagnosis and treatment system and preparation method and application thereof 四川大学 2020-08-14 CN claimed
US-8360149-B2 Surface modification for cross-linking or breaking interactions with injected fluid SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2013-01-29 US claimed
US-20120330044-A1 CHELATING AGENT MODIFIED GRAPHENE OXIDES, METHODS OF PREPARATION AND USE MONTCLAIR STATE UNIVERSITY (US) 2012-12-27 US claimed
WO-2012166916-A1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORPORATION (US) 2012-12-06 WO claimed
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2012-11-01 US claimed
EP-2462188-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER Waters Technologies Corporation (US) 2012-06-13 EP claimed
US-20120081778-A1 PIGMENT-BASED INK HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-04-05 US claimed
WO-2011017418-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2011-02-10 WO claimed
WO-2010070600-A1 SURFACE MODIFICATION FOR CROSS-LINKING OR BREAKING INTERACTIONS WITH INJECTED FLUID SCHLUMBERGER CANADA LIMITED (CA) 2010-06-24 WO claimed
US-20100147515-A1 SURFACE MODIFICATION FOR CROSS-LINKING OR BREAKING INTERACTIONS WITH INJECTED FLUID SCHLUMBERGER TECHNOLOGY CORPORATION 2010-06-17 US claimed
US-4466896-A Ethylenediamine triacetic acid siloxane stabilizers for inorganic silicates in antifreeze/coolant formulations TEXACO INC. (US) 1984-08-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER SPECC1L, SAMM50, RAB5IF CPB2 187/4885GGT1 333/4885CPB1 544/4885
US-20120330044-A1 CHELATING AGENT MODIFIED GRAPHENE OXIDES, METHODS OF PREPARATION AND USE SCO2, AOC1, AOX1 CPB2 1849/4885GGT1 78/4885CPB1 1742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.